« Back
Home /
Anti-CEACAM5 (labetuzumab biosimilar) mAb

Anti-CEACAM5 (labetuzumab biosimilar) mAb

Manufacturer	DIMA Biotechnology
Category	Oncology Metabolism Glucose Homeostasis Cholesterol & Lipid Metabolism Antibodies By Cell Type Carcinoma Hematology Leukemia Obesity ELISA Primary Antibodies By Organ Lung Cancer Bladder Cancer Colorectal Cancer Breast Cancer Testicular & Prostate Cancer Gallbladder Cancer Gastric Cancer Pancreatic Cancer Thyroid Cancer Other Lipid\Cholesterol Metabolism Modulators
Type	Antibody Monoclonal
Specific against	Human
Isotype	IgG1
Format	Liquid
Applications	ELISA
Amount	100 ug
Host	Humanized
Item no.	DIM-BME100035-100ug
Targets	CEACAM5;;CLMP
eClass 6.1	32160702
eClass 9.0	42030590
Available
Clonality	Monoclonal
Purification	Purified from cell culture supernatant by affinity chromatography
Storage	Store at -20C (Avoid repeated freezing and thawing)
Buffer	50% Glycerol; PBS, pH 7.4; 0.1% BSA
Preservative	0.1% Procline 300
Reconstitution	Reconstitute with deionized water
Gene ID	1048
Swiss-Prot	P06731
Related products	PME100071

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 100 ug

available

Delivery expected until 7/4/2024